Detalhe da pesquisa
1.
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.
Blood
; 143(6): 522-534, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946299
2.
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
Blood
; 143(17): 1713-1725, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194692
3.
Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma.
Blood
; 142(10): 878-886, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319435
4.
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies.
Blood
; 142(6): 553-560, 2023 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37257195
5.
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany.
Blood
; 140(4): 349-358, 2022 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316325
6.
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.
Eur J Nucl Med Mol Imaging
; 51(5): 1361-1370, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114616
7.
Time-dependent cost comparison and health economic impact analysis of second-line interventions for transplant-ineligible patients with relapsed or refractory diffuse large B cell lymphoma.
Eur J Haematol
; 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38853698
8.
Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCR.
Eur J Haematol
; 112(6): 957-963, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369814
9.
Low B-cell content is associated with a CD73-low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma.
Br J Haematol
; 201(6): 1097-1102, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921595
10.
Cost-effectiveness analysis of transplant-ineligible relapsed or refractory diffuse large B-cell lymphoma treatment options-Experience of the efficiency frontier approach.
Eur J Haematol
; 111(6): 895-908, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37644352
11.
Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group.
Br J Haematol
; 196(1): 99-104, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34396513
12.
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i).
Br J Haematol
; 196(3): 606-616, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775591
13.
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1.
Blood
; 136(25): 2851-2863, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113552
14.
Early report on the severity of COVID-19 in hematologic patients infected with the SARS-CoV2 omicron variant.
Eur J Haematol
; 109(4): 364-372, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751531
15.
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
Eur J Haematol
; 109(6): 728-735, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056778
16.
Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma.
Eur J Haematol
; 108(5): 403-412, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090068
17.
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(2): 223-234, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539742
18.
Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Br J Haematol
; 193(3): 515-519, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486762
19.
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.
Blood
; 134(14): 1144-1153, 2019 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409671
20.
Whole-slide image analysis of the tumor microenvironment identifies low B-cell content as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP.
Haematologica
; 106(6): 1684-1692, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32381573